Angiotensin II (Ang II) is a major effector of the RAS, is involved in the pathogenesis of renal fibrosis leading to end-stage renal disease, and plays a role as a major determinant in the pressure–natriuresis responses [7,8]. Here, AGT is linked to stage 5 chronic kidney disease.